← FDA DRUG APPROVALS

FDA ANDA · ANDA074815

ALPROSTADIL

Sponsor: HIKMA

APPLICATION
ANDA074815
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-20
LATEST ACTION
2002-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ALPROSTADILPrescription
ALPROSTADIL 0.5MG/ML · INJECTABLE · INJECTION

Approval history

2002-09-11Manufacturing (CMC) · Supplement 5AP
2001-04-03Manufacturing (CMC) · Supplement 4AP
2000-07-11Labeling · Supplement 3AP
2000-07-11Manufacturing (CMC) · Supplement 1AP
2000-07-11Manufacturing (CMC) · Supplement 2AP
1998-01-20OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →